Publication | Closed Access

The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseRheumatic DiseasesImmunologyPharmacologyPsoriatic ArthritisSerum Drug LevelsInflammatory Rheumatic DiseasePharmacotherapyMedicineClinical ResponseRheumatoid Arthritis